Trial Information
Generic NameUstekinumabProduct NameSTELARA®Therapeutic AreaSkin and Connective Tissue DiseasesEnrollment766% Female30.7%% White93.6%
Product ClassAntipsoriaticsSponsor Protocol NumberC0743T08Data PartnerJohnson & JohnsonCondition StudiedPsoriasisMean/Median Age (Years)45.5
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available
Approved Data Requests Associated with this Trial
- 2024-0716 : Validation of causal machine learning methods to identify heterogeneous treatment effects
- 2024-0604 : Bayesian dynamic borrowing of external controls using propensity score-integrated and model-assisted elastic evaluation of heterogeneity
- 2024-0356 : Combining clinical trials with external data: applications in the YODA database
- 2022-4894 : Systemic pharmacological treatments for chronic plaque psoriasis: A Systematic Review and an Individual-Patient Data Network Meta-Analysis of RCTs
- 2019-4067 : Evidence-generation for biologics in pediatric studies
- 2019-3865 : Alternative Data Presentation For Treatment Outcomes in Psoriasis
- 2017-1746 : Heterogeneity in relative treatment efficacy by age, sex, socioeconomic status and comorbidity
- 2017-1706 : Comparison of ?real-life? clinical practice to clinical trials? a propensity score standardization method
- 2015-0339 : Impact of the dose of immunomodulators on pharmacokinetics of biologics: Patient level meta-analysis of randomized controlled trials